91����

On June 18, 2025, the National Institutes of Health (NIH) issued notice NIH NOT-OD-25-127 Implementation Update: Terminating or Suspending Dangerous Gain-of-Function Research in Accordance with the Executive Order on Improving the Safety and Security of Biological Research (external link). Within this notice, NIH provided the following definition of “dangerous gain-of-function research”: “Dangerous gain-of-function research means scientific […]

On March 28, 2025, the National Institutes of Health (NIH) issued implementation update NOT-OD-25: Promoting Maximal Transparency Under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (external link). This updated guidance will require institutions to publicly post approved minutes from all Institutional Biosafety Committee (IBC) meetings held on or after June […]

91���� Institutional Biosafety Committee (IBC) has issued minor revisions to the Policies and Procedures for Research Involving Recombinant or Synthetic Nucleic Acid Molecules or Infectious Agents (Word). These revisions reflect the recent updates to the National Institutes of Health (NIH) Guidelines (issued April 2024) and the revised United States Government Policy for […]

The National Institutes of Health (NIH) has issued revisions to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (external link) as of April 2024 – these revisions will become effective on September 30, 2024. The revisions include: More details about these revisions are available in the Federal Register Notice: Final Action […]

The following message was sent via email to all University of Maine employees on March 20, 2023 by the Office of the Vice President for Research and Dean of the Graduate School. The Office of Research Compliance has worked with the Biosafety Officer, Dr. Andy Holmes, and the Institutional Biosafety Committee (IBC) to review and […]